Children under the age of 12 make up 50 million people in the U.S., but they are not eligible for the vaccine. Parents want to know whether a coronavirus vaccine is available for children under 12 and whether booster doses are likely to be releasing for adults. About one in four new Covid-19 cases involves children.
There are 50 million people under 12 in the United States. One in four new COVID-19 cases involves children. Parents are beginning to wonder whether there is a coronavirus vaccine for children under 12 or whether booster doses are more likely to be releasing for adults.
The American Academy of Pediatrics reported that 26.8 percent of all new COVID-19 cases in the week ending September 2 were children. This is an exponential increase in patients compared to the pandemic’s beginning. Meaning that 252,000 children contracted the virus this week. There is a large part of the population that is not entitling to a vaccine. Despite pressure to increase vaccines for children under 12. “No real data is showing that children under 12 are affected by this pandemic or the new strains”, said Dr. Flor Munoz-Rivas. A professor of pediatrics and infectious diseases at Baylor College of Medicine and child studies investigator at Baylor and Texas Children’s Hospital for the Pfizer Moderna vaccine.
It is difficult to say when the vaccine will be available. Since the research team is conducting studies and collecting data, but experts at the Food and Drug Administration (FDA) believe it will be available this winter. Munoz-Rivas estimates the vaccine could be available in the next few months.
In May, the FDA approved Pfizer’s vaccine for adolescents 12 and older. After approval, the Centers for Disease Control and Prevention (CDC) recommended that all 12-year-olds and older receive a COVID-19 vaccine. The CDC claims the vaccine uses the most intensive safety monitoring system in U.S. history. The Moderna vaccine will soon be available.
The vaccination plan is the same for adults, but the dosage for children is different. Creech said the study uses the exact timetable and schedule for children: 3-week intervals for Pfizer vaccines and 4-week intervals for Moderna. “We have learned over time that extending the interval between doses is beneficial for reducing the risk of disease complications,” Creech continued. Pfizer and Moderna, the two mRNA vaccine manufacturers, have begun clinical trials for children under 12.
‘A more contagious variant’
Compared with the onset of pandemics, children under 12 are now more likely to develop COVID-19. As the delta variant spread and many states stopped veiling themselves. Although, making physical and social dissociations, the number of sick children decreased. However, many children are still not ill enough to increase the total number of Covid-19 cases in children, which means that the number of children hospitalized for the virus has risen sharply.
Munoz-Rivas encourages the use of masks and the practice of physical and social distancing and hand washing to contain the virus. Vaccination is one option, but the most essential way to bring the pandemic under
The U.S. is experiencing an increase in COVID-19 cases and hospitalizations caused by the emergence of the Delta variant. Most new hospitalizations and deaths from the virus occurred among unvaccinated people. According to recent data, the delta variant carries health risks, which are higher among the unvaccinated.
The vaccines and the Delta variant
At this point, 70% of eligible Americans have received at least one dose of the COVID-19 vaccine. And many other countries cannot get enough vaccines to pass. A new CDC report reveals that as of July 26, 6,587 reported infections were leading to hospitalizations and deaths among the 16.3 million people vaccinated, a percentage of 0.01 percent or less. The pandemic remains a race against an infectious and ever-changing virus. An adequately administered vaccine offers the highest level of protection.
What makes the delta variant of coronavirus, first discovered in December in India. So sad is that it is the most contagious version of COVID-19 found in unvaccinated people and infects them most frequently, stated Dr. Amesh A. Adalja, Senior Scientist at the Johns Hopkins Center for Health Security. Access to vaccines is widespread in the United States, but so is the virus itself. Infectious disease experts say large outbreaks among people with non-vaccination could be fueled by highly contagious delta variants. Variants of the virus, called Delta-plus, are the most highly infectious strains. While has detected in several countries, including India, Britain, Portugal, and South Korea. These people are at a higher risk of hospitalization. And many of them are in geographical areas where it is difficult to get to the hospital.
The CDC said in a statement that the delta virus is more contagious than the chickenpox virus. The most common vaccine approved in the United States since 1995. Though, meaning it can spread to more people in less time and create transmission routes among the unvaccinated. Those who carry the delta virus also have a higher viral load, which means they take more viruses and can more easily transmit to others. “We want to be done with this pandemic [COVID-19], and if we don’t, we can take our fight a little longer,” Walensky said.
The CDC recommends wearing masks indoors, even when children too young to get a vaccination, return to the classroom. Experts fear Delta and other variants could bring back, but they say the hope is that the vaccine. An RNA vaccine being developed by Pfizer, Moderna, and AstraZeneca. Hence, will prevent people from developing severe COVID-19 cases that can lead to hospitalization and death.